Moderato

AssetAlso Moderato Plus

Implantable cardiac neuromodulation pacing algorithm modulating blood pressure and autonomic tone.

Stage: Human trials
Modality: Device
Target: Not known; 2
Indications: 1
Trial: 1
Developer

Indications

2

Bradycardia
Human trials, Recruiting, NCT05719454, clinicaltrials.gov, 7 Oct 2026
Hypertension
Human trials, Recruiting, NCT05719454, clinicaltrials.gov, 7 Oct 2026

In the full profile

Owner and partners1
Trials1
Competitors5

Every asset’s record: target, stage, trials and the evidence behind it.

Updated 7 Oct 2026, 1 source